Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age
Annals of Oncology, 10/20/09
Mook S et al. – The 70–gene prognosis signature can accurately select postmenopausal patients at low risk of breast cancer–related death within 5 years of diagnosis and can be of clinical use in selecting postmenopausal women for adjuvant chemotherapy.
Related Articles
KRAS Mutation and Microsatellite Instability: Two Genetic Markers of Early Tumor Development That Influence the Prognosis of Colorectal Cancer
Annals of Surgical Oncology, 10/13/09
Relevance Score: 64%
Analysis of breast cancer related gene expression using natural splines and the Cox proportional hazard model to identify prognostic associations
Breast Cancer Research and Treatment, 11/09/09
Relevance Score: 62%
Predicting response to radiotherapy: Evolutions and revolutions
International Journal of Radiation Biology, 10/29/09
Relevance Score: 45%
Intratumoral Cytokines and Tumor Cell Biology Determine Spontaneous Breast Cancer–Specific Immune Responses and Their Correlation to Prognosis
Cancer Research, 11/03/09
Relevance Score: 43%
A novel role of cyclinD1 and p16 in clinical pathology and prognosis of childhood medulloblastoma
Medical Oncology, 10/09/09
Relevance Score: 43%
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
Bevacizumab and breast cancer: current therapeutic progress and future perspectives
Expert Review of Anticancer Therapy, 12/04/09
Overall survival benefit for weekly vs. three-weekly taxanes regimens in advanced breast cancer: A meta-analysis
Cancer Treatment Reviews, 12/04/09
Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer
Cancer Treatment Reviews, 12/04/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


